Re: Crawford et al.: Long-term Tolerability and Efficacy of Degarelix: 5-Year Results From a Phase III Extension Trial With a 1-Arm Crossover From Leuprolide to Degarelix (Urology 2014;83:1122-1128)

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSofikerim, Mustafa
dc.date.accessioned2025-10-16T15:32:16Z
dc.date.issued2014
dc.identifier.doi10.1016/j.urology.2014.07.053
dc.identifier.otherWOS:000344478700079
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9117
dc.publisherELSEVIER SCIENCE INC
dc.sourceUROLOGY
dc.titleRe: Crawford et al.: Long-term Tolerability and Efficacy of Degarelix: 5-Year Results From a Phase III Extension Trial With a 1-Arm Crossover From Leuprolide to Degarelix (Urology 2014;83:1122-1128)
dc.typeLetter

Dosyalar

Koleksiyonlar

WOS